drug
as of 2026-07-01Exenatide
MeSH D000077270
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Bjorn H. Ebdrup
3 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
3
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
NCT02417142Phase 4Completed
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
NCT00845507Phase 4Completed
Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
NCT01794429Phase 3Completed
KOLs & investigators
3
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
KOL
Xiaoduo Fan, MD, MPH, MS
personKOL score 9
Melissa DelBello, MD
personKOL score 8
Pelle L Ishøy, MD
personKOL score —